129 related articles for article (PubMed ID: 18880597)
1. The haemagglutinin of Haemophilus pertussis; haemagglutinin as a protective antigen in experimental murine pertussis.
KEOGH EV; NORTH EA
Aust J Exp Biol Med Sci; 1948 Jul; 26(Pt 4):315-22. PubMed ID: 18880597
[No Abstract] [Full Text] [Related]
2. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
[TBL] [Abstract][Full Text] [Related]
3. Some factors influencing the virulence of Haemophilus pertussis Phase I.
GRAY DF
Aust J Exp Biol Med Sci; 1946 Dec; 24(4):301-11. PubMed ID: 20257529
[No Abstract] [Full Text] [Related]
4. The behaviour of Haemophilus pertussis in casein hydrolysate broth.
FISHER S
Aust J Exp Biol Med Sci; 1948 Jul; 26(Pt 4):299-306. PubMed ID: 18880595
[No Abstract] [Full Text] [Related]
5. On the protective antigen of phase 1 H. pertussis.
KUWAJIMA Y; MASUI M; SHIMURA N
Yokohama Med Bull; 1952 Jun; 3(3):131-9. PubMed ID: 13029568
[No Abstract] [Full Text] [Related]
6. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
Pittman M
Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
[TBL] [Abstract][Full Text] [Related]
7. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.
Tuomanen E; Weiss A; Rich R; Zak F; Zak O
Dev Biol Stand; 1985; 61():197-204. PubMed ID: 2872105
[TBL] [Abstract][Full Text] [Related]
8. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
[TBL] [Abstract][Full Text] [Related]
10. Studies on the antigenicity of toxic extracts of Hemophilus pertussis.
VERWEY WF; THIELE EH
J Immunol; 1949 Jan; 61(1):27-33. PubMed ID: 18109231
[No Abstract] [Full Text] [Related]
11. [Bacteriology of whooping cough. II. Determination of the major agglutinant factors in Bordetella pertussis samples isolated in Rio de Janeiro].
Ubatuba A; Salmito AT
Hospital (Rio J); 1970; 78(5):1301-10. PubMed ID: 4327251
[No Abstract] [Full Text] [Related]
12. Infectivity of Hemophilus pertussis for the chick embryo.
SHAFFER MF; SHAFFER LS
Proc Soc Exp Biol Med; 1946 Jun; 62(2):244. PubMed ID: 20993182
[No Abstract] [Full Text] [Related]
13. A simplified liquid culture medium for the growth of Hemophilus pertussis.
VERWEY WF; THIELE EH; SAGE DN
J Bacteriol; 1947 Jul; 54(1):71. PubMed ID: 20255167
[No Abstract] [Full Text] [Related]
14. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
15. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
Alonso JM; Rocancourt M; Le Nin S; Brezin C
Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
[No Abstract] [Full Text] [Related]
16. Protection against intranasal infection of mice with Bordetella pertussis.
Robinson A; Ashworth LA; Baskerville A; Irons LI
Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
[TBL] [Abstract][Full Text] [Related]
17. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
[TBL] [Abstract][Full Text] [Related]
19. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
Conway MA; Madrigal-Estebas L; McClean S; Brayden DJ; Mills KH
Vaccine; 2001 Feb; 19(15-16):1940-50. PubMed ID: 11228364
[TBL] [Abstract][Full Text] [Related]
20. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
